CBT-I in Primary Brain Tumor Patients: Phase IIc Randomized Feasibility Pilot Trial
- Conditions
- Primary Brain TumorAstrocytomaOligodendrogliomaPrimary Central Nervous System (CNS) LymphomaMeningiomaGlioblastoma
- Registration Number
- NCT06439420
- Lead Sponsor
- Virginia Commonwealth University
- Brief Summary
This study seeks to investigate an evidence-based, manualized, behavioral health intervention, Cognitive Behavioral Therapy for Insomnia (CBT-I), in individuals with primary brain tumors (PBT) and insomnia. Our project will assess the feasibility and acceptability of recruitment, enrollment, data collection procedures, and retention of individuals with PBT and insomnia in the behavioral health intervention, CBT-I, and investigate the potential benefits of CBT-I within this at-risk and understudied population. In the long term, the goals are to expand treatment options for neuro-oncology patients and improve their mission readiness and overall wellbeing.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 70
- Primary brain tumor diagnosis (grade I-IV)
- >/=2weeks post-cranial resection (if applicable)
- >/=1 month post-radiation therapy (if applicable)
- Able to understand, speak, and read English
- Absence of major cognitive concerns
- Meet Diagnostic and statistical manual of mental disorders version 5 (DSM-V) diagnostic criteria for insomnia
- Reliable internet connection
- Major communication difficulties that would prohibit effective intervention
- Inability to attend weekly virtual group meetings
- Inability to understand and provide informed consent
- Currently a prisoner or residing in a correctional facility
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Rate of baseline assessment completion Week 1 Number of participants that complete the baseline assessment
Rate of post-intervention assessment completion Week 6 The number of participants that complete the post-intervention assessment
Rate of consent to screening procedures Baseline (Day 1) Number of participants that consent to screening procedures
Acceptability of quantity of assessments Week 18 Satisfaction rating of quantity of assessments on a scale of 1-5 with 5 being the best
Rate of intervention attrition Week 6 The number of participants that do not complete the CBT-I intervention
Rate of those eligible enrolling Baseline (Day 1) Number of participants that are eligible to enroll to the protocol
Rate of follow-up assessment completion Week 18 The number of participants that complete the follow-up assessment
Acceptability of timing of assessments Week 18 Satisfaction ratings of timing of assessments on a scale of 1-5 with 5 being the best
Acceptability of duration of assessments Week 18 Satisfaction ratings of duration of assessments on a scale of 1-5 with 5 being the best
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Virginia Commonwealth University
🇺🇸Richmond, Virginia, United States
Virginia Commonwealth University🇺🇸Richmond, Virginia, United States